The global market for Computer Aided Detection (CAD) was estimated at US$1.2 Billion in 2024 and is projected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Computer Aided Detection (CAD) market.
Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.
The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.
Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized
Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.
The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.
SCOPE OF STUDY:
The report analyzes the Computer Aided Detection (CAD) market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Imaging Modality (Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT, Other Imaging Modalities); Application (Oncology, Cardiovascular & Neurological Indications)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Mammography segment, which is expected to reach US$759.0 Million by 2030 with a CAGR of a 9.8%. The MRI segment is also set to grow at 8.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $305.5 Million in 2024, and China, forecasted to grow at an impressive 12.4% CAGR to reach $458.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Computer Aided Detection (CAD) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Computer Aided Detection (CAD) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Computer Aided Detection (CAD) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Agfa-Gevaert NV, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 103 companies featured in this Computer Aided Detection (CAD) market report include:
- Agfa-Gevaert NV
- FUJIFILM Holdings Corporation
- GE Healthcare
- Hitachi Ltd.
- Hologic, Inc.
- iCAD, Inc.
- Invivo Corporation
- Koninklijke Philips NV
- McKesson Corporation
- Merge Healthcare, Inc.
- Siemens Healthineers
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agfa-Gevaert NV
- FUJIFILM Holdings Corporation
- GE Healthcare
- Hitachi Ltd.
- Hologic, Inc.
- iCAD, Inc.
- Invivo Corporation
- Koninklijke Philips NV
- McKesson Corporation
- Merge Healthcare, Inc.
- Siemens Healthineers
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 203 |
Published | June 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 1.2 Billion |
Forecasted Market Value ( USD | $ 2 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |